| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.02 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |